RxDoctor Payments Data
★ My doctorsLook up a doctor →

Loretta Leja

Family Medicine · Cheboygan, MINPI 1831122324

Payments from drug & device makers

$8,830in general payments, 2019–2025

Across 468 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$920
  • Amgen$685
  • Pfizer$556
  • Lilly USA, LLC$551
  • Johnson & Johnson$504
  • plus $4K from 53 others

What the payments were for

  • Food & beverage$8,811100%
  • Education$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)76$1,585
AbbVie(2 entities)54$920
Amgen39$685
Pfizer35$556
Lilly USA, LLC32$551
Johnson & Johnson(2 entities)18$504
Novo Nordisk29$487
Novartis25$452
Merck19$391
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)12$248
Astellas Pharma US Inc11$215
GSK12$187
Otsuka America Pharmaceutical, Inc.7$155
Boehringer Ingelheim8$152
Myriad Genetic Laboratories, Inc.2$129
Sanofi7$120
Globus Medical3$102
Exact Sciences4$97
Seagen Inc.5$85
Takeda Pharmaceuticals U.S.A., Inc.5$81
Xeris Pharmaceuticals, Inc.4$79
Eisai Inc.3$74
Bayer4$68
Axsome Therapeutics, Inc.4$62
Lundbeck LLC3$62
Morphosys, US Inc.3$55
Alkermes, Inc.2$46
Bristol Myers Squibb3$42
Genentech USA, Inc.2$42
Verona Pharma, Inc.2$40
Stemline Therapeutics Inc.2$37
Mylan Specialty L.p.2$34
Kowa Pharmaceuticals America, Inc.2$34
G1 Therapeutics, Inc.2$33
Ironshore Pharmaceuticals Inc.2$32
Beigene USA, Inc.2$31
Rigel Pharmaceuticals, Inc.1$21
Abiomed1$20
EMD Serono, Inc.1$20
Esperion Therapeutics, Inc.1$19
Corcept Therapeutics1$18
Teva Pharmaceuticals USA, Inc.1$17
Servier Pharmaceuticals LLC1$17
Jazz Pharmaceuticals Inc.1$17
Paratek Pharmaceuticals, Inc.1$16
Mirati Therapeutics, Inc.1$16
Supernus Pharmaceuticals, Inc.1$16
Apellis Pharmaceuticals, Inc.1$16
AVEO Pharmaceuticals, Inc.1$15
Hologic Sales And Service, LLC1$15
Blue Earth Diagnostics1$15
Kyowa Kirin, Inc.1$14
Incyte Corporation1$14
Helsinn Therapeutics (U.S.), Inc.1$13
Agios Pharmaceuticals, Inc.1$13
Advanced Respiratory, Inc1$13
Athena Bioscience, LLC1$12
Radius Health, Inc.1$12
Daiichi Sankyo Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,830 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan →

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban127$133,334
FarxigaDapagliflozin Propanediol72$70,299
OzempicSemaglutide38$57,274
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$47,506
Breztri AerosphereBudesonide/Glycopyr/Formoterol56$47,073
EntrestoSacubitril/Valsartan23$43,699
TrulicityDulaglutide41$41,751
VraylarCariprazine Hcl26$39,622
JardianceEmpagliflozin34$38,843
Repatha SureclickEvolocumab52$34,948
MounjaroTirzepatide33$34,752
XareltoRivaroxaban25$34,693
JanuviaSitagliptin Phosphate33$32,906
Bydureon BciseExenatide Microspheres17$19,385
TrintellixVortioxetine Hydrobromide33$19,371

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$556$133,334127 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,585$131,812175 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$187$79,089122 claims
Lilly USA, LLCTrulicity, Mounjaro$551$76,50374 claims
Novo NordiskOzempic$487$57,27438 claims
AbbVieVraylar, Linzess$920$52,38737 claims
Boehringer IngelheimJardiance, Spiriva Respimat$152$46,76145 claims
NovartisEntresto$452$43,69923 claims
Johnson & JohnsonXarelto$504$34,69325 claims
MerckJanuvia$391$32,90633 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$81$19,37133 claims
Astellas Pharma US IncMyrbetriq$215$7,50817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Cheboygan

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →